EFFICACY AND TOXICITY OBSERVED IN MALIGNANT PLEURAL MESOTHELIOMA PATIENTS TREATED IN PHASE I TRIALS AT A SINGLE INSTITUTION

被引：0
|
作者：
Raphael, J. [1 ]
Hollebecque, A. [2 ]
Le Teuff, G. [3 ]
Massard, C. [2 ]
Bahleda, R. [2 ]
Margery, J. [4 ]
Besse, B. [1 ]
Soria, J. [1 ]
Planchard, D. [1 ]
机构：
[1] Inst Gustave Roussy, INSERM, Thorac Grp, U981, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[3] Inst Gustave Roussy, Dept Stat & Epidemiol, Villejuif, France
[4] Percy Hosp, Dept Pulm, Paris, France
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 50 条
  • [31] Malignant pleural mesothelioma: single-institution experience of 101 patients over a 15-year period
    Domen, Andreas
    De Laet, Christophe
    Vanderbruggen, Wies
    Gielis, Jan
    Hendriks, Jeroen M. H.
    Lauwers, Patrick
    Janssens, Annelies
    Hiddinga, Birgitta
    Van Meerbeeck, Jan P.
    Van Schil, Paul E.
    ACTA CHIRURGICA BELGICA, 2017, 117 (03) : 157 - 163
  • [32] Low-dose gemcitabine in prolonged infusion and cisplatin for malignant pleural mesothelioma: a phase I and II trials
    Kovac, V
    Zwitter, M
    Smrdel, U
    Debeljak, A
    Cesar, R
    Izidor, K
    LUNG CANCER, 2004, 45 : S68 - S68
  • [33] A phase I/II study of pemetrexed plus cisplatin in Japanese patients with malignant pleural mesothelioma
    Yamazaki, Kohichi
    Kunitoh, Hideo
    Hida, Toyoaki
    Gemba, Kenichi
    Shinkai, Tetsu
    Ichinose, Yukito
    Nambu, Yoshihiro
    Saijyo, Nagahiro
    Fukuoka, Masahiro
    ANNALS OF ONCOLOGY, 2006, 17 : 230 - 231
  • [34] A phase I/II study of pemetrexed plus cisplatin in Japanese patients with malignant pleural mesothelioma
    Gemba, K.
    Yamazaki, K.
    Kunitoh, H.
    Hida, T.
    Nakagawa, K.
    Shinkai, T.
    Ichinose, Y.
    Nambu, Y.
    Saijo, N.
    Fukuoka, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma
    Jackman, David M.
    Kindler, Hedy L.
    Yeap, Below Y.
    Fidias, Panos
    Salgia, Ravi
    Lucca, Joan
    Morse, Linda K.
    Ostler, Patricia A.
    Johnson, Bruce E.
    Janne, Pasi A.
    CANCER, 2008, 113 (04) : 808 - 814
  • [36] Docetaxel plus Gemcitabine as First-line Treatment in Malignant Pleural Mesothelioma: A Single Institution Phase II Study
    Ralli, Maria
    Tourkantonis, Ioannis
    Makrilia, Nektaria
    Gkini, Eleni
    Kotteas, Elias
    Gkiozos, Ioannis
    Katirtzoglou, Nikolaos
    Syrigos, Kostas
    ANTICANCER RESEARCH, 2009, 29 (08) : 3441 - 3444
  • [37] Hemithoracic radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma: Toxicity and outcomes at an Australian institution
    Bece, Andrej
    Tin, Mo Mo
    Martin, Darren
    Lin, Robert
    McLean, Jocelyn
    McCaughan, Brian
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2015, 59 (03) : 355 - 362
  • [38] Predictors of High Grade Toxicity of Chemotherapy among Malignant Pleural Mesothelioma Patients
    Abou Elkasem, Fatma
    Rahoma, Mohamed
    El Khir, Iman Abou
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S480 - S480
  • [39] A Single-Institution Experience in Percutaneous Image-Guided Biopsy of Malignant Pleural Mesothelioma
    B. T. Welch
    P. W. Eiken
    T. D. Atwell
    T. Peikert
    E. S. Yi
    F. Nichols
    G. D. Schmit
    CardioVascular and Interventional Radiology, 2017, 40 : 860 - 863
  • [40] A Single-Institution Experience in Percutaneous Image-Guided Biopsy of Malignant Pleural Mesothelioma
    Welch, B. T.
    Eiken, P. W.
    Atwell, T. D.
    Peikert, T.
    Yi, E. S.
    Nichols, F.
    Schmit, G. D.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2017, 40 (06) : 860 - 863
12345